Author | Lightnews

Daniel Aletaha @danielaletaha.bsky.social · 6d

Helga Lechner-Radner joined ORF’s Bewusst gesund to discuss “Leben mit Rheuma”.
She highlighted that rheumatic diseases go far beyond joint pain, early diagnosis and modern therapy can truly change lives.
🎥 onepager.orf.at/bewusstgesun...

Studiogespräch: Leben mit Rheuma

onepager.orf.at

Daniel Aletaha @danielaletaha.bsky.social · 25d

I recently shared my thoughts on Austria’s strong global role in rheumatology in my recent Schmerz Nachrichten interview, from @eular.org initiatives to digital innovation and equity in care. Grateful to all who make this collaboration possible. 🇦🇹
link.springer.com/article/10.1...

Österreichs starker Footprint in der globalen Rheuma-Community - Schmerz Nachrichten

Schmerz Nachrichten -

link.springer.com

2

Daniel Aletaha @danielaletaha.bsky.social · Sep 19

At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social
& @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.

4 6

Daniel Aletaha @danielaletaha.bsky.social · Sep 16

New in Journal of Autoimmunity: our study on FAPI PET/CT in myositis-related ILD, led by Kastriot Kastrati & Peter Mandl. Findings show FAPI uptake predicts progression better than standard tools, promising step for personalized care. 📖 doi.org/10.1016/j.ja...

Redirecting

doi.org

Reposted by Daniel Aletaha

AutoPiX project @autopix.bsky.social · Sep 9

🚀 Meet our supportive partner: @inmusc.bsky.social

#InMusc is a Spanish consultancy that helps transform ideas into impact through research and #methodology training. Their mission is to make research collaborations agile, relevant, and meaningful.

1 2 6

Daniel Aletaha @danielaletaha.bsky.social · Sep 8

📢 New from our Division of Rheumatology: Peter Mandl on the expanding role of ultrasound in rheumatology - beyond joints to glands, vessels, lungs & muscles. Real-time, radiation-free imaging for diagnosis & management. 🎥 www.youtube.com/watch?v=XgOO...

Daniel Aletaha @danielaletaha.bsky.social · Sep 1

Our study on how global recruitment patterns affect placebo response in RA trials has gained broad Austrian media coverage (ORF, NÖN, SN & more). Great to see interest in how trial design impacts fair evaluation of new therapies! 🔗 science.orf.at/stories/3231...

Stärkerer Placeboeffekt bei Ärmeren

Der Placeboeffekt und die sozioökonomische Lebensrealität hängen laut Untersuchungen der Wiener MedUni zusammen. In Studien aus ärmeren Ländern reagieren die Probanden und Probandinnen stärker auf das...

science.orf.at

Daniel Aletaha @danielaletaha.bsky.social · Aug 25

Two new papers from our division show that recruiting RA & PsA trial patients in less affluent regions increase placebo rates - likely from limited treatment access. Trial design must adapt.
RA: doi.org/10.1016/j.ar...
PsA: doi.org/10.1002/art....

Redirecting

doi.org

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · Aug 21

Join the 9th EULAR Course on Immunology 2026, a highly interactive course focused on key immunology concepts and practical research project design.

📅 6-7 February 2026
📍Amsterdam, Netherlands
🔔Registration deadline: 2 November 2025
Register here: https://pulse.ly/nul3x4sazs

#eularEDUCATION

1 2

Daniel Aletaha @danielaletaha.bsky.social · Aug 18

Can we collect meaningful patient-reported outcomes in rheumatology using a smartphone app? 📱
Our latest study says YES.
Check it out in RMD Open:
👉 doi.org/10.1136/rmdo...

Collecting patient-reported outcomes via the COTIDIANA smartphone app: a prospective validity study

Background Self-management of rheumatic and musculoskeletal diseases often involves regular assessments of disease-related outcomes. In recent years, smartphone apps are used to collect electronic pat...

doi.org

Reposted by Daniel Aletaha

European Medical Journal @emjreviews.bsky.social · Aug 18

‪Discover more of @danielaletaha.bsky.social‬, @meduniwien.ac.at and past ‪@eular.org‬ president's thoughts on EMJ: www.emjreviews.com/rheumatology...

1 1

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · Aug 12

Join the 8th EULAR Imaging Course 2026, an intensive, hands-on course covering key imaging techniques in rheumatology, from X-ray to MRI and ultrasound.

📅5-6 February 2026
📍Amsterdam, Netherlands
🔔Registration deadline: 2 November 2025
Register here: https://pulse.ly/5a9ni8gnzs

#eularEDUCATION

1 1

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · Aug 1

📸 Behind every project is a team. During the EULAR 2025 Congress in Barcelona, we had the pleasure to meet with members of six research consortia: HIPPOCRATES, SQUEEZE, STRATA-FIT, MDR-RA, PerPrev-CID, and AutoPiX.

👉 Interested in partnering with us? Learn more here: https://pulse.ly/58wj8jwuui

2 7

Reposted by Daniel Aletaha

The European Alliance of Associations for Rheumatology @eular.org · Aug 6

🚀Join us on our #EULAR and #EMEUNET Webinar: "Gender-specific differences in rheumatic diseases"

💻Wednesday, 13 Aug 2025, 18:00-18:45 CEST

Register here👉https://pulse.ly/lqp4vkeeod

#eularEMEUNET #Rheumatology

1 4

Daniel Aletaha @danielaletaha.bsky.social · Aug 7

Can women with systemic autoimmune rheumatic diseases pass on robust immunity to their babies?
Turns out - yes. 👶🛡️
Proud to share our latest collaborative study on maternal antibody transfer in the Journal of Autoimmunity: doi.org/10.1016/j.ja...

Redirecting

doi.org

2

Daniel Aletaha @danielaletaha.bsky.social · Aug 1

At KinderUni 2025, our division of Rheumatology @meduniwien.ac.at explored the fascinating world of autoimmunity with Vienna’s youngest scientists. Huge thanks to our amazing team for inspiring future researchers! 👉 kinderuni-anmeldung.at/event.php?ev...

4

Reposted by Daniel Aletaha

MedUni Wien @meduniwien.ac.at · Jul 10

Idiopathic #inflammatorymyopathies are rare #autoimmunediseases in which the #immunesystem attacks the body's own #musclecells.

A team from #MedUniVienna has systematically described the safety and efficacy of targeted #immunotherapy in refractory idiopathic inflammatory #myopathies. ⬇️

New treatment option investigated for difficult-to-treat muscle inflammation

Details on the results of the retrospective observational study!

www.meduniwien.ac.at

1 3 4

Daniel Aletaha @danielaletaha.bsky.social · Jul 7

New review in Joint Bone Spine co-authored by our team highlights ultrasound's expanding role from joints to organ involvement in rheumatic diseases. Read more 👉 www.sciencedirect.com/science/arti...

Ultrasound in rheumatic and musculoskeletal diseases: From musculoskeletal to organ involvement

In last two decades, the use of ultrasound has assumed an increasingly important role in the assessment of almost all rheumatic and musculoskeletal di…

www.sciencedirect.com

1

Daniel Aletaha @danielaletaha.bsky.social · Jun 30

Great meeting in Stockholm with the @autopix.bsky.social team! Thanks @collectiveminds.bsky.social for hosting. We're advancing AI tools to improve rheumatic care - excited for what’s ahead!

2

Daniel Aletaha @danielaletaha.bsky.social · Jun 26

Check out the interview I made within the frame of #EULAR2025 with the talented EMEUNET Newsletter Sub-Committee members Anastasia Madenidou and Victoria Konzett 👇
emeunews.org/2025/06/01/t...

1

Daniel Aletaha @danielaletaha.bsky.social · Jun 13

Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇
www.youtube.com/watch?v=d6hi...

EULAR 2025 - Interview with Prof. Daniel Aletaha

YouTube video by EULAR

www.youtube.com

3 7

Daniel Aletaha @danielaletaha.bsky.social · Jun 12

Proud to showcase the @squeezeproject.bsky.social at #EULAR2025! Visit booth O9 (near Hall 8.1, NPO area) to learn how we’re advancing precision medicine in RA to get the right treatment to the right patient.

SQUEEZE project @squeezeproject.bsky.social · Jun 11

Our booth is ready! And we are too! The #SQUEEZE booth team @nicoleschmidtvie.bsky.social and @caro-neum.bsky.social is geared up for #EULAR2025. Join us for chats about our three clinical trials, the SQUEEZE Care Model, the HealthBuddy App and #patientengagement.📍 Booth #O3 👥 #Rheumatology #RA

Two people in front of the SQUEEZE congress booth

3

Daniel Aletaha @danielaletaha.bsky.social · Jun 12

Proud of our @autopix.bsky.social at #EULAR2025! Visit us at booth O8 (near Hall 8.1, NPO area) to learn how we’re using AI to advance rheumatic image analysis for better patient care.

AutoPiX project @autopix.bsky.social · Jun 12

The #AutoPiX consortium is making the best out of this #Eular2025 congress. No results yet, but lots of great discussions. Just making the time for a group photo says a lot of the commitment these people have.
Love this project!
Visit our booth for the dot in the i
🍒🍒🍒

5

Reposted by Daniel Aletaha

Lupus Europe @lupuseurope.bsky.social · Jun 11

And that’s the start of what it’s going to be a very exciting @eular.org Congress!

Open ceremony with @danielaletaha.bsky.social

#EULAR2025

1 3

Reposted by Daniel Aletaha

SQUEEZE project @squeezeproject.bsky.social · Jun 2

🎙️ Mark the first of many SQUEEZE talks at #EULAR2025: "Add-on vs. Replacement csDMARDs post-MTX. A European analysis on csDMARD Treatment Choices." Presented by Nils Steinz from Leiden University Medical Center (LUMC) on June 12, at 10:50 am at room A2. #RA #DMARD #PrecisionMedicine

3 7